Dr. Tsewang Tashi
Claim this profileGeorge E Wahlen Department of Veterans Affairs Medical Center
Area of expertise
Acute Myeloid Leukemia
Tsewang Tashi has run 2 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Acute Myelogenous Leukemia
Tsewang Tashi has run 2 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Affiliated Hospitals
George E. Wahlen Department Of Veterans Affairs Medical Center
Huntsman Cancer Institute/University Of Utah
Clinical Trials Tsewang Tashi is currently running
BLU-263
for Systemic Mastocytosis
This trial tests BLU-263 combined with the best possible care for patients with specific conditions whose symptoms are not well-controlled. The medication aims to reduce symptoms by blocking overactive cells.
Recruiting
0 awards
Phase 2 & 3
12 criteria
Venetoclax + HMA
for Acute Myeloid Leukemia
This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3 mutations. Azacitidine is a drug that is absorbed into DNA and leads to the activation of cancer suppressor genes, which are genes that help control cell growth. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Gilteritinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. This study may help doctors find out if these different approaches are better than the usual approaches. To decide if they are better, the study doctors are looking to see if the study drugs lead to a higher percentage of patients achieving a deeper remission compared to the usual approach.
Recruiting
1 award
Phase 2
7 criteria
More about Tsewang Tashi
Clinical Trial Related
4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Tsewang Tashi has experience with
- Azacitidine
- Venetoclax
- BLU-263
- Placebo
- Continuous Positive Airway Pressure
- Avapritinib
Breakdown of trials Tsewang Tashi has run
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Systemic Mastocytosis
Mastocytosis
Polycythemia Vera
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tsewang Tashi specialize in?
Tsewang Tashi focuses on Acute Myeloid Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved FLT3 positive patients, or patients who are D835 positive.
Is Tsewang Tashi currently recruiting for clinical trials?
Yes, Tsewang Tashi is currently recruiting for 4 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Tsewang Tashi has studied deeply?
Yes, Tsewang Tashi has studied treatments such as Azacitidine, Venetoclax, BLU-263.
What is the best way to schedule an appointment with Tsewang Tashi?
Apply for one of the trials that Tsewang Tashi is conducting.
What is the office address of Tsewang Tashi?
The office of Tsewang Tashi is located at: George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah 84148 United States. This is the address for their practice at the George E Wahlen Department of Veterans Affairs Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.